Duration of Meropenem Administration for Sepsis

Standard Duration of Therapy

The standard duration of meropenem therapy for severe infections related to sepsis and septic shock is 7-10 days, as recommended by the Intensive Care Medicine society 1
When meropenem is used as part of empirical combination therapy, the combination should be stopped after 3-5 days and continued with the most appropriate monotherapy once the susceptibility profile is known, according to the Intensive Care Medicine society 1
Daily evaluation is mandatory to identify opportunities for de-escalation of antimicrobial therapy, as recommended by the Intensive Care Medicine society 1

Prolonged meropenem therapy beyond 10 days is required in cases of slow clinical response to initial therapy, as recommended by the Intensive Care Medicine society 1
In cases of undrainable infection foci, meropenem therapy may need to be extended beyond 10 days, according to the Intensive Care Medicine society 1
Bacteremia with Staphylococcus aureus may require longer duration of meropenem therapy, as recommended by the Intensive Care Medicine society 1
Immunological deficiencies, including neutropenia, may require prolonged meropenem therapy, according to the Intensive Care Medicine society 1

In cases of intra-abdominal infections with adequate source control in immunocompetent patients, a duration of 4 days may be sufficient, as recommended by the Praxis Medical Insights society 3
Rapid clinical resolution after effective source control in intra-abdominal or urinary sepsis may allow for shorter duration of meropenem therapy, according to the Praxis Medical Insights society 3

Meropenem should be started within 1 hour of sepsis or septic shock diagnosis, as recommended by the Intensive Care Medicine society 1
A loading dose of 1-2 grams IV should be used, and source control should be performed within 12 hours if possible, according to the Intensive Care Medicine society 1
Blood cultures should be taken before antibiotic administration, if not causing significant delay, as recommended by the Intensive Care Medicine society 1

The guideline still recommends a duration of 7-10 days regardless of the method of administration, as stated by the Intensive Care Medicine society 1
Combination therapy should be stopped after 3-5 days, and meropenem should be continued as monotherapy if the pathogen is sensitive, according to the Intensive Care Medicine society 1
The total dose of meropenem may be lower with continuous infusion, but the guideline recommends a standard duration of 7-10 days, as stated by the Intensive Care Medicine society 1

Therapy should not be extended beyond 10 days without a clear indication, as recommended by the Praxis Medical Insights society 3
Daily reassessment for opportunities to de-escalate therapy should not be missed, according to the Intensive Care Medicine society 1
Combination therapy should not be continued beyond 3-5 days without a strong reason, as recommended by the Intensive Care Medicine society 1
In patients without identified pathogens who have recovered by day 10, therapy can be stopped, according to the Journal of Infection society 5